View in EDS

Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

Saved in:
Bibliographic Details
Title: Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.
Authors: Pelletier M; Novartis (United States) Cambridge, MA United States., Yang J; Novartis Institutes for BioMedical Research Switzerland., Joshi M; Novartis Institutes for BioMedical Research Cambridge, MA United States., Grauel A; Novartis Institutes for Biomedical Research Cambridge United States., Abecunas C; Novartis Institutes for BioMedical Research, Cambridge, MA, USA United States., Altzerinakou MA; Novartis Institutes for BioMedical Research Switzerland., Zhou Z; Novartis Institutes for BioMedical Research, Shanghai, China China., Zhu X; Novartis Institutes for BioMedical Research Cambridge, MA United States., Clark K; Novartis Institutes for BioMedical Research, East Hanover, NJ, USA United States., Li L; Novartis Biomedical Research East Hanover, NJ United States., Bai LY; China Medical University Hospital Taichung Taiwan., Milella M; University of Verona, Verona, Italy Verona, Veneto Italy., Mercade TM; Vall d'Hebron Institute of Oncology Spain., Tai WMD; National Cancer Centre Singapore Singapore Singapore., Bockorny B; Beth Israel Deaconess Medical Center Boston, MA United States., Grell P; Masaryk Memorial Cancer Institute Czech Republic., Sivakumar S; University of Birmingham., Wong MK; Westmead Hospital Australia., Chee CE; National University Hospital Singapore, N/A = Not Applicable Singapore., Aparicio T; Hôpital Saint-Louis Paris France., Prager G; Medical University of Vienna Vienna Austria., Bostel G; Novartis Institutes for BioMedical Research, Cambridge, MA United States., Schiessl B; Novartis Institutes for BioMedical Research, Cambridge, MA United States., Maacke H; Novartis Institutes for BioMedical Research, Cambridge, MA Basel Switzerland., Dranoff G; Dana-Farber Cancer Institute Boston, Massachusetts United States., Shaw A; Dana-Farber Cancer Institute Boston, MA United States., Fabre C; Dana-Farber Cancer Institute Boston United States., Mataraza J; Novartis Institutes for BioMedical Research, Cambridge, MA Cambridge United States., Malek S; Genentech South San Francisco, CA United States., Cremasco V; Novartis Institutes for Biomedical Research Cambridge, MA United States.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jun 25. Date of Electronic Publication: 2026 Jun 25.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42347868
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pelletier+M%22">Pelletier M</searchLink>; Novartis (United States) Cambridge, MA United States.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Novartis Institutes for BioMedical Research Switzerland.<br /><searchLink fieldCode="AU" term="%22Joshi+M%22">Joshi M</searchLink>; Novartis Institutes for BioMedical Research Cambridge, MA United States.<br /><searchLink fieldCode="AU" term="%22Grauel+A%22">Grauel A</searchLink>; Novartis Institutes for Biomedical Research Cambridge United States.<br /><searchLink fieldCode="AU" term="%22Abecunas+C%22">Abecunas C</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA, USA United States.<br /><searchLink fieldCode="AU" term="%22Altzerinakou+MA%22">Altzerinakou MA</searchLink>; Novartis Institutes for BioMedical Research Switzerland.<br /><searchLink fieldCode="AU" term="%22Zhou+Z%22">Zhou Z</searchLink>; Novartis Institutes for BioMedical Research, Shanghai, China China.<br /><searchLink fieldCode="AU" term="%22Zhu+X%22">Zhu X</searchLink>; Novartis Institutes for BioMedical Research Cambridge, MA United States.<br /><searchLink fieldCode="AU" term="%22Clark+K%22">Clark K</searchLink>; Novartis Institutes for BioMedical Research, East Hanover, NJ, USA United States.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Novartis Biomedical Research East Hanover, NJ United States.<br /><searchLink fieldCode="AU" term="%22Bai+LY%22">Bai LY</searchLink>; China Medical University Hospital Taichung Taiwan.<br /><searchLink fieldCode="AU" term="%22Milella+M%22">Milella M</searchLink>; University of Verona, Verona, Italy Verona, Veneto Italy.<br /><searchLink fieldCode="AU" term="%22Mercade+TM%22">Mercade TM</searchLink>; Vall d'Hebron Institute of Oncology Spain.<br /><searchLink fieldCode="AU" term="%22Tai+WMD%22">Tai WMD</searchLink>; National Cancer Centre Singapore Singapore Singapore.<br /><searchLink fieldCode="AU" term="%22Bockorny+B%22">Bockorny B</searchLink>; Beth Israel Deaconess Medical Center Boston, MA United States.<br /><searchLink fieldCode="AU" term="%22Grell+P%22">Grell P</searchLink>; Masaryk Memorial Cancer Institute Czech Republic.<br /><searchLink fieldCode="AU" term="%22Sivakumar+S%22">Sivakumar S</searchLink>; University of Birmingham.<br /><searchLink fieldCode="AU" term="%22Wong+MK%22">Wong MK</searchLink>; Westmead Hospital Australia.<br /><searchLink fieldCode="AU" term="%22Chee+CE%22">Chee CE</searchLink>; National University Hospital Singapore, N/A = Not Applicable Singapore.<br /><searchLink fieldCode="AU" term="%22Aparicio+T%22">Aparicio T</searchLink>; Hôpital Saint-Louis Paris France.<br /><searchLink fieldCode="AU" term="%22Prager+G%22">Prager G</searchLink>; Medical University of Vienna Vienna Austria.<br /><searchLink fieldCode="AU" term="%22Bostel+G%22">Bostel G</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA United States.<br /><searchLink fieldCode="AU" term="%22Schiessl+B%22">Schiessl B</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA United States.<br /><searchLink fieldCode="AU" term="%22Maacke+H%22">Maacke H</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA Basel Switzerland.<br /><searchLink fieldCode="AU" term="%22Dranoff+G%22">Dranoff G</searchLink>; Dana-Farber Cancer Institute Boston, Massachusetts United States.<br /><searchLink fieldCode="AU" term="%22Shaw+A%22">Shaw A</searchLink>; Dana-Farber Cancer Institute Boston, MA United States.<br /><searchLink fieldCode="AU" term="%22Fabre+C%22">Fabre C</searchLink>; Dana-Farber Cancer Institute Boston United States.<br /><searchLink fieldCode="AU" term="%22Mataraza+J%22">Mataraza J</searchLink>; Novartis Institutes for BioMedical Research, Cambridge, MA Cambridge United States.<br /><searchLink fieldCode="AU" term="%22Malek+S%22">Malek S</searchLink>; Genentech South San Francisco, CA United States.<br /><searchLink fieldCode="AU" term="%22Cremasco+V%22">Cremasco V</searchLink>; Novartis Institutes for Biomedical Research Cambridge, MA United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2026 Jun 25. <i>Date of Electronic Publication: </i>2026 Jun 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42347868
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-26-0805
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pelletier M
      – PersonEntity:
          Name:
            NameFull: Yang J
      – PersonEntity:
          Name:
            NameFull: Joshi M
      – PersonEntity:
          Name:
            NameFull: Grauel A
      – PersonEntity:
          Name:
            NameFull: Abecunas C
      – PersonEntity:
          Name:
            NameFull: Altzerinakou MA
      – PersonEntity:
          Name:
            NameFull: Zhou Z
      – PersonEntity:
          Name:
            NameFull: Zhu X
      – PersonEntity:
          Name:
            NameFull: Clark K
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Bai LY
      – PersonEntity:
          Name:
            NameFull: Milella M
      – PersonEntity:
          Name:
            NameFull: Mercade TM
      – PersonEntity:
          Name:
            NameFull: Tai WMD
      – PersonEntity:
          Name:
            NameFull: Bockorny B
      – PersonEntity:
          Name:
            NameFull: Grell P
      – PersonEntity:
          Name:
            NameFull: Sivakumar S
      – PersonEntity:
          Name:
            NameFull: Wong MK
      – PersonEntity:
          Name:
            NameFull: Chee CE
      – PersonEntity:
          Name:
            NameFull: Aparicio T
      – PersonEntity:
          Name:
            NameFull: Prager G
      – PersonEntity:
          Name:
            NameFull: Bostel G
      – PersonEntity:
          Name:
            NameFull: Schiessl B
      – PersonEntity:
          Name:
            NameFull: Maacke H
      – PersonEntity:
          Name:
            NameFull: Dranoff G
      – PersonEntity:
          Name:
            NameFull: Shaw A
      – PersonEntity:
          Name:
            NameFull: Fabre C
      – PersonEntity:
          Name:
            NameFull: Mataraza J
      – PersonEntity:
          Name:
            NameFull: Malek S
      – PersonEntity:
          Name:
            NameFull: Cremasco V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 06
              Text: 2026 Jun 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1